Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication

doi:10.3748/wjg.v28.i1.140

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6591)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

426

WORD

138

HTML

2738

Figures (1-5)

245

Tables (1-2)

296

Sum=3843

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

339

Download

500

Sum=839

Publishing Process of This Article

Item

Count

Browse

532

Download

1377

Sum=1909

Jan 7, 2022 (publication date) through Jul 30, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Jan 7, 2022; 28(1): 140-153
Published online Jan 7, 2022. doi: 10.3748/wjg.v28.i1.140

Full Size Figure Download Figure

Figure 5 Kaplan-Meier survival analysis for chronic hepatitis C patients stratified by the risk scores. IFN: Interferon.

Citation: Lu MY, Yeh ML, Huang CI, Wang SC, Tsai YS, Tsai PC, Ko YM, Lin CC, Chen KY, Wei YJ, Hsu PY, Hsu CT, Jang TY, Liu TW, Liang PC, Hsieh MY, Lin ZY, Chen SC, Huang CF, Huang JF, Dai CY, Chuang WL, Yu ML. Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication. World J Gastroenterol 2022; 28(1): 140-153
URL: https://www.wjgnet.com/1007-9327/full/v28/i1/140.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i1.140